Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Eris Lifesciences Ltd

NSE: ERIS · BSE: 540596 · Pharmaceuticals & Biotechnology · 17 announcements

Share price: ₹1,258.90
Market cap: ₹17,466 Cr
Revenue (annual): ₹3,129 Cr
Net profit (annual): ₹619.5 Cr
P/E (TTM): 27.1×Sector 50.4×
Promoter holding: 54.14%+0.22% QoQ
FII holding: 5.76%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 7 Management Change 2 Financial Results 2 Annual General Meeting 2 Price Movement Clarification 1 Employee Stock Options 1 Debt & Borrowing 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

29 Jul 2026 13:10 IST BSE

Financial Results

Eris Lifesciences Q1 FY27 Results: Net Profit ₹143.3 Cr, Up 14.5% YoY

Eris Lifesciences Ltd reported revenue from operations of ₹873.2 Cr (+13.0% YoY) and net profit of ₹143.3 Cr (+14.5% YoY) for Q1 FY27.

Key figure: Net profit ₹143.3 Cr · +14.5% YoY

Open full results → Read the filing ↗

20 May 2026 14:39 IST BSE

Financial ResultsAlfa Alert

Eris Lifesciences Q4 FY26 Results: Net Profit ₹279.1 Cr, Up 172.8% YoY

Eris Lifesciences Ltd reported revenue from operations of ₹756.6 Cr (+7.3% YoY) and net profit of ₹279.1 Cr (+172.8% YoY) for Q4 FY26.

Key figure: Net profit ₹279.1 Cr · +172.8% YoY

Open full results → Read the filing ↗